Nodal lymphangiogenesis promotes distant lymph node (LN) metastasis in experimental cancer models. However, the role of nodal lymphangiogenesis in distant metastasis and in the overall survival of cancer patients remains unknown. Therefore, we investigated mechanisms that might facilitate regional and distant LN metastasis in extramammary Paget's disease (EMPD). We retrospectively analyzed the impact of tumor-induced lymphatic vessel activation on the survival of 116 patients, the largest cohort with EMPD studied to date. Nodal lymphangiogenesis was significantly increased in metastatic, compared with tumor-free, LNs (P ؍ 0.022). Increased lymphatic invasion within regional LNs was significantly associated with distant metastasis in LN (P ؍ 0.047) and organs (P ؍ 0.003). Thus, invasion within regional LNs is a powerful indicator of systemic tumor spread and reduced patient survival in EMPD (P ؍ 0.0004). Lymphatic vessels associated with tumors expressed stromal cell-derived factor-1 (SDF-1), whereas CXCR4 was expressed on invasive The metastatic spread of cancer cells from a primary site generally occurs in sentinel lymph nodes (LNs). Thus, the presence and extent of LN metastasis determines staging and prognosis in most human malignancies and often guides therapeutic decisions.1 Although surgical resection of primary tumors and their regional LN metastases can cure several types of cancer, distant LN and organ metastases represent a significant therapeutic concern due to the absence of effective antimetastatic therapies.